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SUMMARY 
From March 1962 to April 1966, 118 patients were treated with renal 
transplantation, 3 with kidneys from identical twins, 9 with cadaveric 
homografts, and 106 with homogrnfts from volunteer donors. Sixty-two 
of the patients are still alive after nine months to almost five years. 
The only completely satisfactory group was that of the identical twin 
recipicnts. 
The results after homot,ransplantation hare not materially improved 
during this time despite the acquisition of increased experience, adjust- 
ments of timing and dosage of azathioprine and prednisone, and attempts 
to identify biologically suitable donors in advance of operation by tissue 
typing. I t  is suggested that an impasse has been reached, beyond which 
further reduction in mortality and morbidity will depend primarily upon 
the effective application of new immunosuppressive techniques. 
I n  spite of the increasing acceptance during the last five years of renal 
homotransplantation as a legitimate clinical undertaking, those responsible 
for the care of such patients have been keenly aware of the imperfections of 
the therapeutic techniques employed during this time. Invcstigatsrs in 
several centers including our own have tried to  vary systematically the timing 
and dosage of the two most important immunosuppressive agents, azathio- 
prine and prednisone. Furthermore, efforts have been made to apply antigen- 
matching techniques for donor selectioi~ with the hope of thereby reducing 
the need for these drugs. 
I n  this report, we will suggest that an impasse has been reached, imposed 
by the inherent limitations of the agents used to control rejection. A survey 
of our own experience has shown that the acquisition of increased experience, 
the institution of variations in therapy, and even the application of antigen 
typing methods for donor selection have not eliniinated or even significantly 
reduced the morbidity and mortality after transplantation. The cases can 
be divided into four groups. 
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IDENTICAL TWINS TRAXSPLANTS 
All three patients had glomerulonephritis. They were 27, 20, and 54 years 
old when their operations were performed 58,42, and 9 months ago. Each now 
has normal renal function although the patient with the longest follow-up 
has had persistent microscopic hematuria for almost five years. A biopsy in 
the second casc after two years was normal. 
FIRST LIVING DONOR SERIES 
These 64 patients were operated upon from 34 to  50 months ago. Forty-six 
received kidneys from family members (20 parents, 23 siblings, and 3 aunts, 
uncles, or cousins) ; the other 18 donors were nonrelated. No other effort 
was made to match donor-recipient pairs than, with a few exceptions, to  ensure 
against ABO blood group incompatibilities. The first 45 patients were treated 
solely with azathioprine until rejection developed, a t  which time prednisone 
was added. The last 19 received both drugs from the beginning. Actinomycin 
C and local homograft irradiation were used irregularly. 
Thirty-two of the patients are still alive. The survival of the recipients of 
related kidneys is 29 of 46 (63%). In  contrast, only three of the 18 patients 
in the nonrelated group (16.7%) remain alive (Fig. I ) ,  one by virtue of 
a second graft after 2y2 years. 
The change in the timing of prednisone administration in the second part 
of the series did not result in an increase in the total amount of this drug 
which was given. By using large quantities of steroids from the beginning, 
the incidence of severe early rejections was reduced, making i t  possible t o  
attenuate dosage a t  a more rapid rate. The consequent balancing effect is 
shown in Figure 2 in which the average dose per day for the first 105 days 
was found to be almost identical for the recipients of related homografts in 
both the earlier and later groups who lived this long; analysis of the nonrelated 
cases revealed the same thing. 
During the acquisition of the series, there was a trend to conservatism in 
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FIGURE 1. Survival in the first series of 64 patients treated with homografts from living 
donors. All patients are alive beyond the points indicated by the vertical arrows. Follow-up 
is thus 34 to 50 months. 
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FIGURE 2. Analysis of doscs of immunosuppression in the two fractions of the first and 
in the second series of homotransplantations from living related donors. The division of the 
first group was on the basis of differences in the administration of steroids; the first pa- 
tients ( a )  rewired Prednisone for the specific indication of rejection and the later patients 
(b)  rrceived this drug prophylactically from the time of operation. The data are from the 
first 105 postoperative days; patients who failed to live this long were excluded. The influ- 
ence of these changes on the white cell counts and creatinine clearance is shown. 
the use of azathioprine (Fig. 2) which reflected growing apprehension about 
the acute bone marrow depression which was then a common complication. 
An expected corollary change was an increase in the white cell counts (Fig. 
2) .  
Average renal function, illustrated in terms of creatinine clearance was 
slightly better in the second group of patients who were treated from the 
beginning with prednisone (Fig. 2) but the difference was not statistically 
significant. 
Studies of these original cases provided hope that future results could be 
improved using white cell antigen matching in donor selection. Thirty-seven 
of the original 64 patients who survived for a t  least one year were typed by 
Terasaki along with their respective donors. It was found that the best 
clinical results tended to he in those cases with a high degree of donor- 
recipient compatibility of lymphocyte antigens. Furthermore, there was a 
very firm correlation between the completeness of this matching and the 
quality of preservation in the homograft biopsies studied at  about two years 
( 2 ) .  
SECOND LIVING DONOR SERIES 
These 42 patients received homografts 9 to  27 months ago from volunteers 
who were chosen insofar as possible on the basis of the best available 
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FIGURE 3. Survl\.al in the first year following homotransplantation in the second living 
donor srries. The patients included have been followed from 12 to 27 months. One of the 
nonrelated group subsequently died after 17 nlontl~s. 
antigen match. In 25 cases, there were related donors (15 parents, 9 siblings, 
1 uncle). Because the selectivity within most families was limited, the 
quality of matching was only slightly (and not significantly) better than 
could have been achie~ed with random intrafamilial pairing; the donor pool 
for the 17 nonrelated cases was a large one allowing much greater discrimina- 
tion ( 3 ) .  Immunosuppression was similar to that in the previous series except 
that prednisone was usually started in relatively small doses on the day of 
operation and later increased if required for control of rejection. 
Twenty-five of the patients are still alive, 17 of 25 (68%) in the related 
and 8 of 17 (47%) in the unrelated groups. The statistics for the first 36 
cases, all operated upon 12 months or longer ago are shown for the first 
year in Figure 3. The survival after one year was slightly worse in the related 
cases (63.1%) than in the original series, but i t  was better (53%) in the 
nonrelated cases; one of the latter patients subsequently died of hepatitis 
after 17 months. With the delay in mortality which distinguished the second 
from the first series, an almost universal lethal factor in unsuccessfully 
treated cases was found to be infection with uncommon fungal, protozoan, 
and viral organisms. The resultant change in the character of the autopsy 
findings has been discussed in detail by Hill (1). 
The previously described tendency to use smaller closes of azathioprine, 
which had already been noted during the treatment of the original series 
of patients, continued (Fig. 2) into the last group. Now, however, the 
penalty became the need to use higher maintenance doses of prednisone; the 
data shown are from the related cases, but analysis of the nonrelated trans- 
plantations revealed exactly the same thing. I n  spite of this adjustment the 
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rreatinine clearances during the first 105 days mas distinctly poorer ( p  < 0.05) 
than in the first series (Fig. 2) .  The incidence of acute failure from drug 
toxicity had thus been greatly reduced but a t  the expense of less adequate 
lionlograft protection, a delayed lnortality which is ap t  to be a t  least as 
great as in the original series sinre several of the patients still living are not 
tloirig well, and an unquestionably increased long-term morbidity. 
Biopsies of seven of these hoinografts were obtained a t  approximately two 
ycars. Kone were normal and only two were free of more or less serious 
structural abnormalities. 
CADAT'ERIC SERIES 
Three recipients, provided with cadaveric homografts in 1963, died within 
4 to 39 days with unrelieved uremia. In  the last 10 to 14 months, six more 
sinlilar attempts were made; all of the kidneys functioned following delays 
of 10 rllinutes to 23 days after revascularization. Four of these recipients died 
after 3, 8, 10, and 12% nlonths with failing grafts and with septic complica- 
tions of the kind described in the preceding section. An additional patient 
who had normal function for the first seven months had a late uncontrolled 
rejection and is awaiting homograft removal and retransplantation. The 
final patient is one year postoperative with normal renal function. 
The foregoing observations rnake it clear that, if renal homotransplantation 
lias become a standard form of therapy for terminal renal disease, it has 
achieved this status prematurely. Every active transplantation center has its 
brilliant results, but the incidence of failure is high and, what is worse, i t  
seems to have reached an irreducible minimum employing the "standard" im- 
munosuppressive agents. I n  our own institutions, the progressively more timid 
use of azatliioprine, combined with altered programs of prednisone adminis- 
tration, has ~ i r t u a l l y  eliminated the early postoperative deaths from acute 
bone marrow depression, but a t  the expense of later diminished function and 
a higher ultimate steroid need in many cases. The eventual mortality has 
remained relatively fixed with each surh adjustment in management. 
I t  is equally discouraging to  note tha t  the use of prospective antigen 
matching for donor selection did not have more influence upon prognosis. 
This was not surprising in the consanguineous transplantations since selec- 
tivity could not be significantly improved due to the problem of supply. 
This was not the situation, however, in the nonrelated cases where the one-year 
survival mas upgraded by only 20%, reaching the still unsatisfactory figure 
of 53%. The latter finding emphasizes the futility, with the presently avail- 
able therapeutic protocols, of envisioning effective and large scale application 
of tissue typing techniques in cadaver programs. 
This does not imply either that the tissue typing methods now being 
developed are not a direct or indirect measure of histocompatibility factors, 
or that the use of these techniques will play an insignificant role in trans- 
plantation practices of the future. Indeed, evidence has been cited earlier 
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from many of these same cases ( 2 )  that the ultimate damage imposed upon 
the homografts of patients who achieve long-term survival is directly related 
to the degree of antigen nonconformity between donors and recipients. 
Instead, it suggests that antigen matching techniques cannot receive a 
fair trial with the treatment programs now widely being used unless trans- 
plantation is performed only between almost perfectly matched pairs or, 
alternatively, that they require for exploitation a setting of far more adequate 
immunosuppression. The former approach would limit consideration to all 
but a very small number of patients who need this kind of therapy. The 
latter dcveloprnent would allow extension rather than restriction of the 
indications for acceptance into a transplantation program. Investigations of 
new methods of immunosuppression, reported elsewhere in this symposium, 
provide hope this objective can be realized. 
REFERENCES 
I. Hill, R. B. Jr.; Dahrling, B. E. 11; Starzl, T. E.; Rifkind, D.  1967. Am. J. Med. 46: 327. 
2. Porter, K. A.; Rendall, J. M.; Stolinski, C.; Terasaki, P. I.; Marchioro, T. L.; Staral, 
T. E. 1966. Ann. New York Acad. Sci. 129: 615. 
3. Terasaki, P. I.;  Porter, K. A.; Marchioro, T .  L.; Mickey, M. R.; Vredevoe, D.  L.; 
Faris, T. D.; Starzl, T. E. 1966. Ann. New York Acad. Sci. 129: 500. 
